The ethical and legal foundations of scientific ‘conflict of interest’

Law and Ethics in Biomedical Research: Regulation, Conflict of Interest and Liability

Volumn , Issue , 2006, Pages 63-81

  Krimsky, Sheldon ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956367740     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. Marcia Angell and Jerome P. Kassirer, ‘Editorials and Conflicts of Interest,’ Editorial (1996) 335 New Eng. J. Med. 1055.
2. Catherine D. DeAngelis, Phil B. Fontanarosa, and Annette Flanagin, ‘Reporting Financial Conflicts of Interest and Relationships between Investigators and Research Sponsors,’ Editorial (2001) 286 J. Am. Med. Assʼn 89.
3. Dennis F. Thompson, ‘Understanding Financial Conflicts of Interest’ (1993) 329 New Eng. J. Med. 573.
4. Diana Crane, Invisible Colleges: Diffusion of Knowledge in Scientific Communities (Chicago: University of Chicago Press, 1972) at 35.
5. John Herman Randall, The Making of the Modern Mind (Boston: Houghton Mifflin, 1976).
6. Henry Margenau, Ethics and Science (Princeton, NJ: D. Van Nostrand, 1964) at 138.
7. Jacob Bronowski, Science and Human Values (New York: Harper & Row, 1965) at 70.
8. Robert K. Merton, Social Theory and Social Structure (New York: Free Press, 1949).
9. Andrew Stark, Conflict of Interest in American Public Life (Cambridge, MA: Harvard University Press, 2000).
10. Dennis Cauchon, ‘FDA Advisors Tied to Industry,’ USA Today (25 September 2000) 1A at 10A.
11. Jennifer Washburn, ‘Informed Consent,’ Washington Post, 20 December 2001, W16.
12. John Ziman, Real Science (Cambridge: Cambridge University Press, 2000) at 162.
13. Richard C. Lewontin, Steven Rose, and Leon J. Kamin, Not in Our Genes (New York: Pantheon Books, 1984) at 107.
14. ‘Avoid Financial "Correctness,"’ Editorial (1997) 385 Nature 469.
15. ‘Declaration of Financial Interests,’ Editorial (2000) 412 Nature 751.
16. Henry T. Stelfox et al., ‘Conflict of Interest in the Debate Over Calcium-Channel Antagonists’ (1998) 338 New Eng. J. Med. 101.
17. Lise L. Kjaergaard and Bodil Als-Nielsen, ‘Association Between Competing Interests and Authors’ Conclusions: Epidemiological Study of Randomized Clinical Trials Published in BMJ’ (2002) 325 Brit. Med. J. 249.
18. John Yaphe et al., ‘The Association Between Funding by Commercialized Interests and Study Outcome in Randomized Controlled Drug Trials’ (2001) 18 Family Practice 565.
19. Mark Friedberg et al., ‘Evaluation of Conflict of Interest in Economic Ana lyses of New Drugs Used in Oncology’ (1999) 282 J. Am. Med. Assʼn 1453.
20. Sheldon Krimsky, ‘Conflict of Interest and Cost-Effectiveness Analysis’ (1999) 282 J. Am. Med. Assʼn 1474.
21. Christina Turner and George J. Spilich, ‘Research into Smoking or Nicotine and Human Cognitive Performance: Does the Source of Funding Make a Difference?’ (1997) 92 Addiction 1423.
22. Marcia Angell, Testimony (Plenary Presentation at the Conference on Human Subject Protection and Financial Conflicts of Interest, Department of Health and Human Services, National Institutes of Health, Bethesda, MD., 15-16 August 2000) at 36, http://www.aspe.hhs.gov/sp/coi/8-16.htm.
23. Justin E. Bekelman, Yan Li, and Cary P. Gross, ‘Scope and Impact of Financial Conflicts of Interest in Biomedical Research’ (2003) 289 J. Am. Med. Assʼn 454.
24. Deborah E. Barnes and Lisa A. Bero, ‘Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions’ (1998) 279 J. Am. Med. Assʼn 1566.
25. Deborah E. Barnes and Lisa A. Bero, ‘Industry-Funded Research and Conflict of Interest: An Analysis of Research Sponsored by the Tobacco Industry Through the Center for Indoor Air Research’ (1996) 21 J. Health Pol’y. 516.
26. Sheldon Rampton and John Stauber, Trust Us, We’re Experts (New York: Putnam, 2001).
27. Marvin S. Legator, ‘Industry Pressures on Scientific Investigators’ (1998) 4 Int’l J. Occup’l & Envtl. Health 133.
28. Marion Nestle, Food Politics (Berkeley: University of California Press, 2003) at 118.
29. ‘Safeguards at Risk: John Graham and Corporate America’s Back Door to the Bush White House’ (Washington, DC: Public Citizen, 2001).
30. Brian C. Martinson, Melissa S. Anderson, and Raymond deVries.‘Scientists Bahaving Badly, Nature (9 June 2005) 435: 737-8.
31. Ziman, Real Science at 175.
32. Sheldon Krimsky, Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? (Lanham, MD: Rowman & Littlefield, 2003) at 227.
33. Lisa A. Bero, ‘Accepting Commercial Sponsorship: Disclosure Helps - But Is not a Panacea’ (1999) 319 Brit. Med. J. 653.